← FDA Drug Approvals (Drugs@FDA)

ZIPRASIDONE MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2019-12-26

Drug application

FDA Application #

ANDA211908

Application type

Abbreviated New Drug Application (Generic)

Brand name

ZIPRASIDONE MESYLATE

Generic name

ZIPRASIDONE MESYLATE

Active ingredients

ZIPRASIDONE MESYLATE

Dosage form

POWDER

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Fosun Pharma USA Inc.

First approval

2019-12-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown